Literature DB >> 22137646

Motivational assessment of non-treatment buprenorphine research participation in heroin dependent individuals.

Gina Papke1, Mark K Greenwald.   

Abstract

BACKGROUND: Heroin abuse remains an important public health problem, particularly in economically disadvantaged areas. Insight into this problem is gained from interviewing addicted individuals. However, we lack systematic data on factors that motivate heroin users to participate in non-treatment research that offers both financial incentives (compensation) and non-financial incentives (e.g., short-term medication). AIM: To better understand the relative importance of several types of personal motivations to participate in non-treatment buprenorphine research, and to relate self-motivations to social, economic, demographic and drug use factors.
METHODS: Heroin dependent volunteers (N=235 total; 57 female and 178 male; 136 African American, 86 Caucasian, and 13 Other) applied for non-therapeutic buprenorphine research in an urban outpatient setting from 2004 to 2008. We conducted a semi-structured behavioral economic interview, after which participants ranked 11 possible motivations for research participation.
RESULTS: Although the study was repeatedly described as non-treatment research involving buprenorphine, participants often ranked some treatment-related motivations as important (wanting to reduce/stop heroin use, needing a medication to get stabilized/detoxify). Some motivations correlated with income, heroin use, and years since marketing of buprenorphine. Two dimensions emerged from principal component analysis of motivation rankings: (1) treatment motivation vs. greater immediate needs and (2) commitment to trying alternatives vs. a more accepting attitude toward traditional interventions. In summary, heroin addicts' self-motivations to engage in non-therapeutic research are complex--they value economic gain but not exclusively or primarily--and relate to variables such as socioeconomic factors and drug use.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22137646      PMCID: PMC3306501          DOI: 10.1016/j.drugalcdep.2011.11.005

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  36 in total

1.  An ethical framework for the practice of paying research subjects.

Authors:  Terrence F Ackerman
Journal:  IRB       Date:  1989 Jul-Aug

2.  Inducement in research.

Authors:  Martin Wilkinson; Andrew Moore
Journal:  Bioethics       Date:  1997-10       Impact factor: 1.898

3.  Methodological, practical, and ethical challenges to inner-city health research.

Authors:  Ahmed M Bayoumi; Stephen W Hwang
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

Review 4.  Ending concerns about undue inducement.

Authors:  Ezekiel J Emanuel
Journal:  J Law Med Ethics       Date:  2004       Impact factor: 1.718

5.  The Tridimensional Personality Questionnaire: U.S. normative data.

Authors:  C R Cloninger; T R Przybeck; D M Svrakic
Journal:  Psychol Rep       Date:  1991-12

6.  Sociodemographic and motivational characteristics of parents who volunteer their children for clinical research: a controlled study.

Authors:  S C Harth; Y H Thong
Journal:  BMJ       Date:  1990-05-26

7.  For love or money? An exploratory study of why injecting drug users participate in research.

Authors:  C Fry; R Dwyer
Journal:  Addiction       Date:  2001-09       Impact factor: 6.526

8.  Participation of children in clinical research: factors that influence a parent's decision to consent.

Authors:  Alan R Tait; Terri Voepel-Lewis; Shobha Malviya
Journal:  Anesthesiology       Date:  2003-10       Impact factor: 7.892

9.  BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study.

Authors:  Mark K Greenwald; Caren L Steinmiller; Elzbieta Sliwerska; Leslie Lundahl; Margit Burmeister
Journal:  Addict Biol       Date:  2012-02-16       Impact factor: 4.280

10.  Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy.

Authors:  V Jenkins; L Fallowfield
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

View more
  2 in total

1.  Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers.

Authors:  Eric A Woodcock; Leslie H Lundahl; Mark K Greenwald
Journal:  Drug Alcohol Depend       Date:  2014-11-26       Impact factor: 4.492

2.  Heroin delay discounting: Modulation by pharmacological state, drug-use impulsivity, and intelligence.

Authors:  Jonathan J K Stoltman; Eric A Woodcock; Jamey J Lister; Leslie H Lundahl; Mark K Greenwald
Journal:  Exp Clin Psychopharmacol       Date:  2015-12       Impact factor: 3.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.